Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Gastroenterology  |  Immunology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Ulcerative Colitis Clinical Trials

A listing of Ulcerative Colitis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (450) clinical trials

We’re restructuring how we treat the disease. For some people with ulcerative colitis (UC), current medications may bring unwanted side effects or may not work well enough to treat symptoms.   The ECO-RESET Study will look at an investigational medication to see how safe it is and if it may ...

Phase N/A

ULCERATIVE COLITIS IS AN INFLAMMATORY BOWEL DISEASE THAT CAUSES LONG-LASTING INFLAMMATION AND ULCERS (SORES) IN YOUR DIGESTIVE TRACT.  

Phase

The PRECIOUS Study: Predicting Crohn’s & Colitis Outcomes in the United States If you are between the ages of 16-80 and suffer from Crohn’s disease or ulcerative colitis (UC), you may be eligible to participate in this research study. What is this study about? The PRECIOUS study is testing the ...

Phase N/A

Ulcerative Colitis (UC) is another form of inflammatory bowel disease (IBS). Unlike Crohn’s, which can affect any part of the digestive tract, UC only affects the colon and rectum. This disease causes ulcers in the lining of the large intestine but can affect the entire colon.  

Phase N/A

The purpose of this study is to determine whether etrasimod is a safe and effective treatment for moderately to severely active ulcerative colitis.  

Phase

The cause is unknown, however, experts think it may be caused by the immune system overreacting to normal bacteria in the digestive tract, viruses, or other kinds of bacteria. Hereditary factors also play a roll as you are more likely to get UC if other people in your family have ...

Phase N/A

Local doctors are looking for people with Ulcerative Colitis for clinical research studies of an investigational medication. Must be receiving treatment for Ulcerative Colitis Must be at least 18 years old Ulcerative Colitis must be present for at least 3 months prior to first visit  

Phase N/A

To demonstrate the efficacy of study drug, SER-287, to induce clinical remission in patients with active mild-to-moderate ulcerative colitis.  

Phase

This Phase 2 study is designed to evaluate the efficacy and safety of itacitinib in men and women with moderate to severe UC. The study consists of Part A and Part B, which consist of 12 weeks of double-blind, randomized, placebo-controlled treatment periods followed by 40 weeks open label extension ...

Phase

The primary objectives of this study are to evaluate the safety and efficacy of filgotinib in the induction and maintenance treatment of moderately to severely active ulcerative colitis (UC) in participants who are biologic-naive and biologic-experienced. Participants who complete the study, or do not meet protocol response or remission criteria ...

Phase